Endo Pharmaceuticals Holdings Inc.
100 Endo Boulevard
Chadds Ford,
PA 19317
United States - Map
Phone: 610-558-9800
Fax: 610-558-8979
Web Site: http://www.endo.com
| Endo Pharmaceuticals Holdings Inc., a pharmaceutical company, engages in the research, development, sale, and marketing of branded and generic prescription pharmaceuticals for treating and managing pain primarily in the United States. Its products include Lidoderm, a topical patch product for the relief of the pain associated with post-herpetic neuralgia; Opana ER and Opana for the relief of moderate-to-severe pain in patients; Percocet and Percodan tablets; Frova for the treatment of migraine headaches in adults; and Voltaren Gel for the relief of the pain of osteoarthritis of joints amenable to topical treatment. The companys products also include Sanctura for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency; Sanctura XR to treat OAB symptoms; Supprelin LA for treating central precocious puberty (CPP) or the early onset of puberty in children; Vantas provides histrelin, a luteinizing hormone-releasing hormone (LHRH) agonist, for the palliative treatment of advanced prostate cancer; Delatestryl for the treatment of male hypogonadism; Hydron Implant; and Valstar, a sterile solution of valrubicin for intravesical instillation. Its development stage products include Nebido for treatment of hypogonadisml; PRO 2000, a Phase III clinical stage product for the prevention of infection by HIV and other sexually-transmitted pathogens; octreotide implant, a Phase III clinical stage product for the treatment of acromegaly; and axomadol, a Phase II clinical stage product for the treatment of moderate to moderately severe chronic pain and diabetic peripheral neuropathic pain. The companys generic products include Morphine Sulfate and Endocet, an oxycodone hydrochloride and acetaminophen product. It has strategic alliances with Novartis AG, Hind Healthcare, Penwest Pharmaceuticals Co., and Vernalis Development Limited. The company was founded in 1997 and is headquartered in Chadds Ford, Pennsylvania. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. David P. Holveck , 63
Chief Exec. Officer, Pres, Director, Chief Exec. Officer of Endo Pharmaceuticals Inc and Pres of Endo Pharmaceuticals Inc |
$
1.35M |
$
0 | Ms. Caroline B. Manogue Esq., 40
Chief Legal Officer, Exec. VP and Sec. |
$
685.00K |
$
0 | Mr. Ivan Gergel M.D., 48
Exec. VP of R&D |
$
782.00K |
$
0 | Mr. Edward J. Sweeney , 39
Principal Accounting Officer, VP and Controller |
$
333.00K |
$
0 | Ms. Joyce N. LaViscount , 46
VP of Sales Operations |
$
378.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.29% Nasdaq 
Profile
